Cannabinoid pouches

Abstract

The present invention relates to apertured pouches comprising a fibrous matrix containing a cannabinoid and/or terpene ingredient, including kits, methods of use and methods of manufacture.

We claim: 
     
         1 . A pouch for administration of a cannabinoid, comprising a fibrous matrix material incorporating a plurality of apertures defining a sealed pouch, and a cannabinoid containing fill material positioned within the sealed pouch. 
     
     
         2 . The pouch for administration of a cannabinoid of  claim 1 , further comprising a terpene in the cannabinoid containing fill material. 
     
     
         3 . The pouch for administration of a cannabinoid of  claim 1 , wherein each of the plurality of apertures is defined by an aperture size of between about 400 μm to about 800 μm in diameter. 
     
     
         4 . The pouch for administration of a cannabinoid of  claim 1 , wherein each of the plurality of apertures is defined by an aperture size of above about 400 μm in diameter. 
     
     
         5 . The pouch for administration of a cannabinoid of  claim 1 , wherein the pouch is adapted to release between 40% to 90% of the cannabinoid present in the fill material in under 10 minutes when placed in a mouth of a user. 
     
     
         6 . The pouch for administration of a cannabinoid of  claim 3 , wherein at least about 50% of the plurality of apertures have the identified size. 
     
     
         7 . The pouch for administration of a cannabinoid of  claim 3 , wherein at least about 90% of the plurality of apertures have the identified size. 
     
     
         8 . The pouch for administration of a cannabinoid of  claim 1 , wherein the each of the plurality of apertures is circular in shape. 
     
     
         9 . The pouch for administration of a cannabinoid of  claim 1 , wherein the cannabinoid containing fill material comprises cannabidiol, coconut coir, a terpene, a natural oil, a sweetener, a stabilizer and a flavorant. 
     
     
         10 . The pouch for administration of a cannabinoid of  claim 9 , wherein the coconut coir is comprised of coconut coir particles having a mean size range of between about 800 μm to at or about 900 μm. 
     
     
         11 . The pouch for administration of a cannabinoid of  claim 1 , wherein the cannabinoid containing fill material comprises water dispersible cannabidiol and/or cannabidiol isolate. 
     
     
         12 . The pouch for administration of a cannabinoid of  claim 1 , wherein the plurality of apertures comprise holes extending through the fibrous matrix material. 
     
     
         13 . The pouch for administration of a cannabinoid of  claim 1 , wherein the cannabinoid containing fill material comprises an electrospun nanofiber, wherein the electrospun nanofiber comprises cannabidiol. 
     
     
         14 . The pouch for administration of a cannabinoid of  claim 1 , wherein the cannabinoid containing fill material comprises a cannabinoid selected from the group consisting of one or more of cannabidiol (CBD); cannabinol; cannabigerol; cannabichromene; cannabidivarol; tetrahydrocannabidiol; tetrahydrocannabigerol; tetrahydrocannabichromene; tetrahydrocannabidivarol; Δ 8 -THC, and carboxylic acid precursors of the foregoing. 
     
     
         15 . The pouch for administration of a cannabinoid of  claim 1 , wherein the cannabinoid containing fill material comprises a terpene selected from the group consisting of one or more of borneol, caryophyllene, cineole/eucalyptol, delta3carene, limonene, linolool, myrcene, pinene, pulegone, d-limonene linalool, 1,8-cineole (eucalyptol), terpineol-4-ol, p-cymene, Δ-3-carene, β-sitosterol, or β-caryophyllene.cannflavin A, apigenin, and quercetin. 
     
     
         16 . The pouch for administration of a cannabinoid of  claim 1 , wherein the cannabinoid containing fill material comprises a blended composition having a total weight, and cannabinoid containing fill material includes the cannabinoid between about 5% to at or about 20% of the total weight. 
     
     
         17 . The pouch for administration of a cannabinoid ingredient of  claim 1 , wherein the fibrous matrix material is selected from one or more of coconut coir, kenaf, abaca, flax, hemp, jute, ramie, sisal, rice, bamboo, corn husk, silk husk, fruit skin, straw, soy, mint leaf, spearmint leaf, lettuce leaf, synthetic fibers, animal-derived fibers, chitin, and kudzu root. 
     
     
         18 . A pouch for administration of a cannabinoid, comprising a fibrous matrix material incorporating a plurality of apertures defining a sealed pouch, and a cannabinoid ingredient containing fill material positioned within the sealed pouch, wherein
 the cannabinoid ingredient containing fill material comprises a cannabinoid and/or a terpene;   the fibrous matrix material selected from one or more of coconut coir, kenaf, abaca, flax, hemp, jute, ramie, sisal, rice, bamboo, corn husk, silk husk, fruit skin, straw, soy, mint leaf, spearmint leaf, lettuce leaf, synthetic fibers, animal-derived fibers, chitin, and kudzu root;   the cannabinoid ingredient containing fill material further comprises one or more of a natural oil, a sweetener, a stabilizer, or a flavorant; and   wherein the pouch is adapted to release between 40% to 90% of the cannabinoid present in the fill material in under 15 minutes when placed in a mouth of a user.   
     
     
         19 . A pouch for administration of a cannabinoid, comprising a fibrous matrix material incorporating a plurality of apertures defining a sealed pouch, and a cannabinoid ingredient containing fill material positioned within the sealed pouch and at least about 90% of the plurality of apertures is defined by an aperture size of between about 200 μm to about 1000 μm in diameter, wherein the plurality of apertures are present in the fibrous matrix material at an aperture density of between 1 to 100;
 the cannabinoid ingredient containing fill material comprises a cannabinoid and/or a terpene; 
 the fibrous matrix material selected from one or more of coconut coir, kenaf, abaca, flax, hemp, jute, ramie, sisal, rice, bamboo, corn husk, silk husk, fruit skin, straw, soy, mint leaf, spearmint leaf, lettuce leaf, synthetic fibers, animal-derived fibers, chitin, and kudzu root; 
 the cannabinoid ingredient containing fill material further comprises one or more of a natural oil, a sweetener, a stabilizer, or a flavorant; and 
 wherein the pouch is adapted to release between 40% to 90% of the cannabinoid present in the fill material in between 5 to 10 minutes when placed in a mouth of a user. 
 
     
     
         20 . The pouch for administration of a cannabinoid of  claim 19 , wherein the cannabinoid containing fill material comprises a cannabinoid selected from the group consisting of one or more of cannabidiol (CBD); cannabinol; cannabigerol; cannabichromene; cannabidivarol; tetrahydrocannabidiol; tetrahydrocannabigerol; tetrahydrocannabichromene; tetrahydrocannabidivarol; Δ 8 -THC, and carboxylic acid precursors of the foregoing, and wherein the cannabinoid containing fill material comprises a terpene selected from the group consisting of one or more of borneol, caryophyllene, cineole/eucalyptol, delta3carene, limonene, linolool, myrcene, pinene, pulegone, d-limonene linalool, 1,8-cineole (eucalyptol), terpineol-4-ol, p-cymene, Δ-3-carene, β-sitosterol, or β-caryophyllene.cannflavin A, apigenin, and quercetin.